DNA Sequencing Market Research Reports & Industry Analysis

DNA sequencing is a fast-growing market that contributes to various fields such as healthcare, agriculture, and forensics. Many of the world’s most innovative life sciences companies use DNA sequencing technologies to develop novel products and treatments. To help you stay informed in this rapidly evolving landscape, MarketResearch.com offers an array of DNA sequencing industry reports packed with data and expert analysis.

DNA Sequencing Market Size Data

  • We bring together comprehensive and reliable research from a variety of expert analysts to help save you valuable time.
  • Search our collection to quickly find information on DNA sequencing market size, segmentation, the competitive landscape, and leading vendors.
  • Learn about new technological advancements, disruptive trends, and other hot topics.

Your Research Partner

For more than twenty years, MarketResearch.com has assisted clients worldwide in making informed business decisions. We serve investment banks, management consulting firms, major Fortune 500 companies, and leading life science firms. Our team of research specialists is here to guide you through this information-rich landscape. From your initial questions to the final stages of your research, we are ready to offer tailored suggestions and ongoing support.

...Show More ...Show Less


DNA Sequencing Industry Research & Market Reports

  • Whole Genome Sequencing: Global Markets

    ... for each segment. It provides market estimates and forecasts based on the product and service type, sequencing type, workflow end user, application and region. By product and service, the market is segmented into instruments, consumables ... Read More

  • Microbiome Sequencing Service Market, By Service Type (6S rRNA gene profiling, Whole genome shotgun sequencing, Targeted gene sequencing, Single-cell sequencing, and Others), By Application (Gut microbiome analysis, Urinary microbiome analysis, and Others), By End User (Academic and research institutes, Pharmaceutical and Biotechnology companies, Diagnostic laboratories, and Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

    ... sequencing technologies to study the microbial communities within and associated with the human body. The human microbiome refers to the genomes of all microorganisms that reside on or within bodies. Advances in next-generation sequencing technologies ... Read More

  • The 2026-2031 World Outlook for CRISPR and Cas Genes

    ... in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric ... Read More

  • The 2026-2031 World Outlook for Carrier Screenings

    ... (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which ... Read More

  • The 2026-2031 World Outlook for DNA and RNA Sample Preparation Workstations

    ... the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. ... Read More

  • The 2026-2031 World Outlook for DNA Extractor

    ... (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which ... Read More

  • The 2026-2031 World Outlook for DNA and RNA Sample Preparations

    ... country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using ... Read More

  • The 2026-2031 World Outlook for CRISPR Technologies

    ... (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which ... Read More

  • The 2026-2031 World Outlook for Biotechnology DNA Sequencing Market

    ... in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric ... Read More

  • The 2026-2031 World Outlook for CRISPR Genome Editing and Genome Engineering

    ... the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. ... Read More

  • The 2026-2031 World Outlook for DNA Sequencing

    ... (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which ... Read More

  • The 2026-2031 World Outlook for DNA Sequencing Diagnostics

    ... question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models ... Read More

  • The 2026-2031 World Outlook for DNA Sequencing Products

    ... question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models ... Read More

  • The 2026-2031 World Outlook for CRISPR-CAS9 Mice Models

    ... question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models ... Read More

  • DNA and Gene Chip

    ... 2030, growing at a CAGR of 10.3% over the analysis period 2024-2030. Consumables, one of the segments analyzed in the report, is expected to record a 10.2% CAGR and reach US$12.6 Billion by the end ... Read More

  • Mice Model

    ... CAGR of 5.3% over the analysis period 2024-2030. CRISPR / CAS9, one of the segments analyzed in the report, is expected to record a 6.5% CAGR and reach US$976.7 Million by the end of the ... Read More

  • Gene Panel

    ... CAGR of 19.7% over the analysis period 2024-2030. Cancer Risk Assessment, one of the segments analyzed in the report, is expected to record a 21.2% CAGR and reach US$4.8 Billion by the end of the ... Read More

  • DNA Sequencing

    ... CAGR of 11.8% over the analysis period 2024-2030. Consumables, one of the segments analyzed in the report, is expected to record a 11.5% CAGR and reach US$7.5 Billion by the end of the analysis period. ... Read More

  • Metagenomic Sequencing

    ... CAGR of 17.6% over the analysis period 2024-2030. Reagents & Consumables, one of the segments analyzed in the report, is expected to record a 19.4% CAGR and reach US$4.3 Billion by the end of the ... Read More

  • Biotechnology Reagents

    ... CAGR of 4.4% over the analysis period 2024-2030. Chromatography, one of the segments analyzed in the report, is expected to record a 3.4% CAGR and reach US$40.6 Billion by the end of the analysis period. ... Read More

  • SNP Genotyping and Analysis

    ... 2030, growing at a CAGR of 18.6% over the analysis period 2024-2030. SNP Genotyping by Microarrays and GeneChips, one of the segments analyzed in the report, is expected to record a 22.1% CAGR and reach ... Read More

  • Short-Read Sequencing

    ... CAGR of 10.0% over the analysis period 2024-2030. Next-Generation Sequencing, one of the segments analyzed in the report, is expected to record a 9.6% CAGR and reach US$25.0 Billion by the end of the analysis ... Read More

  • Lab-on-a-Chip

    ... 9.4% over the analysis period 2024-2030. Instruments, one of the segments analyzed in the report, is expected to record a 10.0% CAGR and reach US$8.0 Billion by the end of the analysis period. Growth in ... Read More

  • CRISPR Technology

    ... CAGR of 20.9% over the analysis period 2024-2030. Products, one of the segments analyzed in the report, is expected to record a 20.1% CAGR and reach US$6.1 Billion by the end of the analysis period. ... Read More

  • Microbial Identification

    ... CAGR of 11.5% over the analysis period 2024-2030. Instruments, one of the segments analyzed in the report, is expected to record a 9.7% CAGR and reach US$5.0 Billion by the end of the analysis period. ... Read More

< prev 1 2 3 4 5 6 7 8 9 10

Research Assistance

Live help

Join Alert Me Now!

Sign Up

Find out more on our blog
Cookie Settings